维普期刊资源整合服务平台（V6.5）

1080篇 您的检索式：期刊名="Pulm Pharmacol Ther"

选中清除导出查看参考文献查看引证文献引用追踪共54页首页上一页第1页下一页末页 /54 跳转

	题名	作者	年代	出处	被引量
1	Budesonide/formoterol in a single inhaler rapidly relieves methacholine - induced moderate - to - severe bronchoconstriction 显示文摘	Van der Woude H J Boorsma M Bergqvist PBF	2004	Pulm Pharmacol Ther2004，17，2：	1
2	Comparison of twice-daily inhaled ciclesonide and fluticasone propio- nate in patients with moderate-to-severe persistent asthma显示文摘	Bateman ED Linnhof AE Homik L	2008	Pulm Pharmacol Ther2008，21，2：	1
3	The effect of selective phosphodiesterase isoenzyme inhibition on neutrophil function in vltro显示文摘	Jones NA Boswell-Smith V Lever R	2005	Pulm Pharmacol Ther2005，1，2：	1
4	Selective serotonin reuptake inhibitor use and out comes in pulmonary arterial hypertension显示文摘	Kawut SM Horn EM Berekashvili KK	2006	Pulm Pharmacol Ther2006，19，5：	1
5	Effectofacalcium sensitization modulator,Y-27632,on isolated human bronchus and pulmonary artery 显示文摘	YamagataS IchinoseM Sugiura H	2000	Pulm Pharmacol Ther2000，13，1：	1
6	Sensory nerves and airway inflammation:role of A delta and C-fibres显示文摘	Belvisi M G	2003	Pulm Pharmacol Ther2003，16，1：	1
7	Viral epidemiology of acute exacerbations of chronic obstructive pulmonary disease 显示文摘	Dimopoulos G Lerikou M Tsiodras S	2012	Pulm Pharmacol Ther2012，25，1：	1
8	Biomarkers in lower respiratory tract infections显示文摘	BLASI F STOLZ D PIFFER F	2010	Pulm Pharmacol Ther2010，23，6：	1
9	Serum levels of tumor necrosis factorrelated apoptosis-inducing ligand correlate with the severity of pulmonary hypertension显示文摘	Liu H Yang E Lu X	2015	Pulm Pharmacol Ther2015，15，7：	1
10	Anti-inflammatory effect of a selective I kappa B kinase-beta inhibitor in rat lung in response to LPS and cigarette smoke显示文摘	Rajendrasozhan S Hwang JW Yao HA Rahman I	2010	Pulm Pharmacol Ther2010，23，3：	1
11	The long and short of beta β2-agonists显示文摘		2002	Pulm Pharmacol Ther2002，15，6：	1
12	Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist显示文摘	Tilton RG Munsch CL Sherwood SJ Chen YF Wu C	2000	Pulm Pharmacol Ther2000，13，：	1
13	The biology of vascular endothelial growth factor-B(VEGF-B)显示文摘	Nash AD Baca M Wright C Scotney PD	2006	Pulm Pharmacol Ther2006，19，1：	1
14	The PPARgamma ligand, rosigiitazonc, reduces airways hyperresponsiveness in a murine model of allergen-induced inflammation 显示文摘	Ward JE Fernandes D J Taylor CC	2006	Pulm Pharmacol Ther2006，19，1：	1
15	Abnormalities of renal endothelin during acute exacerbation in chronic obstructive pul- monary disease显示文摘	Sofia M Maniscalco M Celentano L	2001	Pulm Pharmacol Ther2001，14，4：	1
16	Effects of inhaled for- moterol compared with salbutamol in ventilated preterm infants 显示文摘	Rieger-Fackeldey E Reinhardt D Schulze A	2004	Pulm Pharmacol Ther2004，17，5：	1
17	Pharmacokinetic interaction profile of riociguat, a new soluble guanylate cyclase stimulator, in vitro显示文摘	Verena R Walter EH Johanna W	2014	Pulm Pharmacol Ther2014，28，2：	1
18	Inhaled corticosteroids reduce asthma-associated airway hyperperfusion through genomic and nongenomic mechanisms显示文摘	Horvath G Vasas S Wanner A	2007	Pulm Pharmacol Ther2007，20，2：	1
19	Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure显示文摘	Matera M G Martuscelli E Cazzola M	2010	Pulm Pharmacol Ther2010，23，1：	1
20	Biomarkers in lower respiratory tract infections显示文摘	Blasi F Stolz D Piffer F	2010	Pulm Pharmacol Ther2010，23，6：	1

返回顶部每页显示：

共54页首页上一页第1页下一页末页 /54 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示